- Home
- PCRX vs OLP Comparison
PCRX vs OLP Comparison
Compare PCRX & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- OLP
- Stock Information
- Founded
- PCRX 2006
- OLP 1982
- Country
- PCRX United States
- OLP United States
- Employees
- PCRX N/A
- OLP N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- OLP Real Estate Investment Trusts
- Sector
- PCRX Health Care
- OLP Real Estate
- Exchange
- PCRX Nasdaq
- OLP Nasdaq
- Market Cap
- PCRX 1.2B
- OLP 569.9M
- IPO Year
- PCRX 2011
- OLP N/A
- Fundamental
- Price
- PCRX $24.02
- OLP $23.80
- Analyst Decision
- PCRX Buy
- OLP Strong Buy
- Analyst Count
- PCRX 9
- OLP 1
- Target Price
- PCRX $29.89
- OLP $28.00
- AVG Volume (30 Days)
- PCRX 526.9K
- OLP 70.5K
- Earning Date
- PCRX 07-29-2025
- OLP 08-05-2025
- Dividend Yield
- PCRX N/A
- OLP 7.59%
- EPS Growth
- PCRX N/A
- OLP N/A
- EPS
- PCRX N/A
- OLP 1.35
- Revenue
- PCRX $702,772,000.00
- OLP $92,152,000.00
- Revenue This Year
- PCRX $7.54
- OLP $11.87
- Revenue Next Year
- PCRX $10.78
- OLP $4.72
- P/E Ratio
- PCRX N/A
- OLP $17.59
- Revenue Growth
- PCRX 3.08
- OLP 3.31
- 52 Week Low
- PCRX $11.16
- OLP $22.32
- 52 Week High
- PCRX $29.33
- OLP $30.45
- Technical
- Relative Strength Index (RSI)
- PCRX 36.83
- OLP 39.64
- Support Level
- PCRX $23.85
- OLP $23.67
- Resistance Level
- PCRX $25.16
- OLP $25.51
- Average True Range (ATR)
- PCRX 0.79
- OLP 0.53
- MACD
- PCRX -0.12
- OLP -0.15
- Stochastic Oscillator
- PCRX 8.20
- OLP 6.28
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.